Form 4 for PGEN PRECIGEN, INC.
Accepted 2023-03-28 00:00:00 ET · period of report 2023-03-24 · accession 0000950103-23-004827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-28 | 2023-03-24 | PGEN | Shah Rutul R | COO | M - OptEx | — | +31.0K | 93.0K | +50% | — |
| DM | 2023-03-28 | 2023-03-24 | PGEN | Shah Rutul R | COO | A - Grant | $0.00 | +133.3K | 92.9K | New | $0 |
| D | 2023-03-28 | 2023-03-24 | PGEN | Shah Rutul R | COO | M - OptEx | $0.00 | -31.0K | 61.9K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-24 | M | A | 30,960 | — | 92,997 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| 2 | Derivative | Option to Purchase Common Stock (Right to Buy) | 2023-03-24 | A | A | 40,409 | $0.00 | 40,409 | D | $0.96 · 2024-03-24 to 2033-03-24 | 40,409 Common Stock | |
| 3 | Derivative | Restricted Stock Units | 2023-03-24 | A | A | 92,880 | $0.00 | 92,880 | D | — · — to — | 92,880 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. (F2) 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. |
| 4 | Derivative | Restricted Stock Units | 2023-03-24 | M | D | 30,960 | $0.00 | 61,920 | D | — · — to — | 30,960 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. (F3) Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. |